Literature DB >> 17416780

Health care utilization by adult long-term survivors of hematopoietic cell transplant: report from the Bone Marrow Transplant Survivor Study.

Sadhna M Shankar1, Andrea Carter, Can-Lan Sun, Liton Francisco, K Scott Baker, James G Gurney, Daniel G Weisdorf, Stephen J Forman, Leslie L Robison, Marcia Grant, Smita Bhatia.   

Abstract

The high intensity of therapy and prolonged immune suppression after hematopoietic cell transplantation (HCT) increase the risk of long-term complications and health care needs among survivors. The aim of this study was to evaluate the current status of health care utilization by long-term HCT survivors and to identify factors associated with lack of utilization. A total of 845 individuals who had undergone HCT between 1974 and 1998 at age 21 years or older and survived 2 or more years after HCT participated in the study. Health care utilization was assessed through a mailed questionnaire in three domains: general contact with health care system, general physical examination, and cancer/HCT-related visit. The median age at HCT was 38.2 years, and the median length of follow-up was 6.4 years. Overall, 98% of allogeneic and 94% of autologous HCT survivors reported medical contact 11+ years after HCT. Cancer/HCT-related visits decreased with increasing time from HCT (allogeneic HCT, 98-57%; autologous HCT, 94-63%). The prevalence of general physical examination increased with time (allogeneic HCT, 56-74%; autologous HCT, 72-81%). Primary care physicians provide health care for an increasing number of adult long-term survivors of HCT, emphasizing the need for increased awareness of the long-term follow-up needs of the HCT survivors by the health care providers.

Entities:  

Mesh:

Year:  2007        PMID: 17416780     DOI: 10.1158/1055-9965.EPI-06-0714

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  20 in total

1.  An investigation of survivorship clinic attendance among childhood cancer survivors living in a five-state rural region.

Authors:  Judy Y Ou; Rochelle R Smits-Seemann; Yelena P Wu; Jennifer Wright; Anne C Kirchhoff
Journal:  J Cancer Surviv       Date:  2017-11-29       Impact factor: 4.442

Review 2.  Long-term health impacts of hematopoietic stem cell transplantation inform recommendations for follow-up.

Authors:  Smita Bhatia
Journal:  Expert Rev Hematol       Date:  2011-08       Impact factor: 2.929

3.  Late cardiovascular complications after hematopoietic cell transplantation.

Authors:  Eric J Chow; Kenneth Wong; Stephanie J Lee; Kara L Cushing-Haugen; Mary E D Flowers; Debra L Friedman; Wendy M Leisenring; Paul J Martin; Beth A Mueller; K Scott Baker
Journal:  Biol Blood Marrow Transplant       Date:  2014-02-22       Impact factor: 5.742

Review 4.  Survivorship after allogeneic transplantation-management recommendations for the primary care provider.

Authors:  André Tichelli; Alicia Rovó
Journal:  Curr Hematol Malig Rep       Date:  2015-03       Impact factor: 3.952

5.  Survivor and Clinician Assessment of Survivorship Care Plans for Hematopoietic Stem Cell Transplantation Patients: An Engineering, Primary Care, and Oncology Collaborative for Survivorship Health.

Authors:  Colleen M Morken; Amye J Tevaarwerk; Amanda K Swiecichowski; James E Haine; Zachary T Williams; Kirsten Norslien; Natalia Arroyo; Xiao Zhang; Bethaney Campbell; Eneida A Mendonca; Mark B Juckett; Mary E Sesto
Journal:  Biol Blood Marrow Transplant       Date:  2019-02-11       Impact factor: 5.742

6.  Healthcare utilization in women after abdominal surgery for ovarian cancer.

Authors:  Ruth McCorkle; Sangchoon Jeon; Elizabeth Ercolano; Peter Schwartz
Journal:  Nurs Res       Date:  2011 Jan-Feb       Impact factor: 2.381

7.  Priorities for Improving Outcomes for Nonmalignant Blood Diseases: A Report from the Blood and Marrow Transplant Clinical Trials Network.

Authors:  John E Levine; Joseph H Antin; Carl E Allen; Lauri M Burroughs; Kenneth R Cooke; Steven Devine; Helen Heslop; Ryotaro Nakamura; Julie An Talano; Gregory Yanik; Nancy DiFronzo
Journal:  Biol Blood Marrow Transplant       Date:  2020-02-05       Impact factor: 5.742

8.  Ethnic differences in chronic health conditions after hematopoietic cell transplantation: a report from the Bone Marrow Transplant Survivor Study.

Authors:  Saro H Armenian; Can-Lan Sun; Jennifer Berano Teh; Mukta Arora; K Scott Baker; Liton Francisco; Stephen J Forman; Smita Bhatia
Journal:  Cancer       Date:  2010-09-01       Impact factor: 6.860

9.  The preventive health behaviors of long-term survivors of cancer and hematopoietic stem cell transplantation compared with matched controls.

Authors:  Michelle M Bishop; Stephanie J Lee; Jennifer L Beaumont; Michael A Andrykowski; J Douglas Rizzo; Kathleen A Sobocinski; John R Wingard
Journal:  Biol Blood Marrow Transplant       Date:  2009-09-23       Impact factor: 5.742

10.  Financial Hardship and Patient-Reported Outcomes after Hematopoietic Cell Transplantation.

Authors:  Gregory A Abel; Randy Albelda; Nandita Khera; Theresa Hahn; Diana Y Salas Coronado; Oreofe O Odejide; Kira Bona; Reginald Tucker-Seeley; Robert Soiffer
Journal:  Biol Blood Marrow Transplant       Date:  2016-05-13       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.